Enzymotec (ENZY) Q1 EPS Outpaces Views

Enzymotec (NASDAQ: ENZY) reported Q1 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $14 million versus the consensus estimate of $13.85 million.

For earnings history and earnings-related data on Enzymotec (ENZY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15